Bg pattern

INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Insulatard 100UI/ml(International Units/ml) injectable suspension in a vial

Human insulin

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

1. What is Insulatard and what is it used for

Insulatard is a human insulin with a gradual onset of action and long duration.

Insulatard is used to reduce high blood sugar levels in patients with diabetes mellitus (diabetes). Diabetes is a disease in which your body does not produce enough insulin to control your blood sugar levels. Treatment with Insulatard helps to prevent complications of diabetes.

Insulatard starts to reduce your blood sugar level about 1 hour and a half after injection and the effect lasts for approximately 24 hours. Insulatard is usually administered in combination with fast-acting insulin preparations.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using Insulatard

Do not use Insulatard

  • If you are allergic to human insulin or any of the other ingredients of this medicine, see section 6.
  • If you suspect you are starting to suffer from hypoglycemia (low blood sugar level), see Summary of serious and very common side effects in section 4.
  • In insulin infusion pumps.
  • If the protective cap is missing or is loose. All vials have a plastic safety cap. If this is not in perfect condition when you acquire the vial, return it to the supplier.
  • If it has not been stored correctly or if it has been frozen, see section 5.
  • If the resuspended insulin does not have a uniformly white and cloudy appearance.

If any of these circumstances apply, do not use Insulatard. Consult your doctor, pharmacist, or nurse.

Before using Insulatard

?Check the label to ensure it is the correct type of insulin.

? Remove the protective cap.

? Always use a new needle for each injection to avoid contamination.

? Needles and syringes must not be shared.

Warnings and precautions

Some changes and activities can affect your insulin needs. Consult your doctor:

  • If you have kidney, liver, adrenal, pituitary, or thyroid problems.
  • If you do more physical exercise than usual or if you want to change your usual diet, as this may affect your blood sugar level.
  • If you are ill, you should continue using insulin and consult your doctor.
  • If you are going to travel abroad, traveling to different time zones may affect your insulin requirement and the time of administration.

Skin changes at the injection site

The injection site should be rotated to help avoid changes in the fatty tissue, such as thickening of the skin, shrinking of the skin, or lumps under the skin. Insulin may not work very well if injected into a thickened, shrunk, or lumpy area (see section 3). Inform your doctor if you notice any changes in the injection site. Inform your doctor if you are currently injecting into these affected areas before starting to inject into a different area. Your doctor may advise you to check your blood sugar levels more closely and adjust your insulin or the dose of your other antidiabetic medications.

Other medicines and Insulatard

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines

Some medicines affect your blood sugar level, and this may mean that your insulin dose needs to be adjusted. The following are the most common medicines that may affect your insulin treatment.

Your blood sugar level may decrease (hypoglycemia) if you take:

  • Other medicines for the treatment of diabetes
  • Monoamine oxidase inhibitors (MAOIs) (used to treat depression)
  • Beta-blockers (used to treat high blood pressure)
  • Angiotensin-converting enzyme inhibitors (ACE inhibitors) (used to treat certain heart conditions or high blood pressure)
  • Salicylates (used to relieve pain and lower fever)
  • Anabolic steroids (such as testosterone)
  • Sulfonamides (used to treat infections).

Your blood sugar level may increase (hyperglycemia) if you take:

  • Oral contraceptives (birth control pills)
  • Thiazides (used to treat high blood pressure or excessive fluid retention)
  • Glucocorticoids (such as cortisone, used to treat inflammation)
  • Thyroid hormone (used to treat thyroid disorders)
  • Sympathomimetics (such as epinephrine [adrenaline], salbutamol, or terbutaline, used to treat asthma)
  • Growth hormone (medication to stimulate bone and somatic growth and with significant influence on the body's metabolic processes)
  • Danazol (medication that acts on ovulation).

Octreotide and lanreotide (used to treat acromegaly, a rare hormonal disorder that usually occurs in middle-aged adults, caused by excess production of growth hormone in the pituitary gland) may increase or decrease your blood sugar level.

Beta-blockers (used to treat high blood pressure) may weaken or completely suppress the early warning symptoms that help recognize low blood sugar levels.

Pioglitazone (tablets used to treat type 2 diabetes)

Some patients with long-standing type 2 diabetes and previous heart disease or stroke who were treated with pioglitazone and insulin developed heart failure. Inform your doctor as soon as possible if you have signs of heart failure such as unusual shortness of breath, rapid weight gain, or localized swelling (edema).

If you have taken any of the medicines on this list, inform your doctor, pharmacist, or nurse.

Using Insulatard with alcohol

? If you drink alcohol, your insulin needs may change, as your blood sugar level may increase or decrease. Strict monitoring is recommended.

Pregnancy and breastfeeding

? If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. Insulatard can be used during pregnancy. It may be necessary to adjust the insulin dose during pregnancy and after delivery. Keeping a strict control of diabetes, especially to prevent hypoglycemia, is important for the health of your baby.

? There are no restrictions on the use of Insulatard during breastfeeding.

Consult your doctor, pharmacist, or nurse before using this medicine during pregnancy or breastfeeding.

Driving and using machines

? Ask your doctor if you can drive vehicles or operate machinery:

  • If you have frequent episodes of hypoglycemia.
  • If you have difficulty recognizing the symptoms of hypoglycemia.

If your blood sugar level is high or low, it may affect your concentration and reaction ability and, therefore, your ability to drive or operate machinery. Be aware that you may put yourself or others at risk.

Insulatard contains sodium

Insulatard contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to use Insulatard

Dose and when to use the insulin

Follow the instructions for administration of this medicine and the dose indicated by your doctor exactly. If you are in doubt, consult your doctor, pharmacist, or nurse again.

Do not change your insulin unless your doctor tells you to. If your doctor changes you from one type or brand of insulin to another, you may need to adjust your dose.

Use in children and adolescents

Insulatard can be used in children and adolescents.

Use in special patient groups

If you have kidney or liver failure or if you are over 65 years old, you should check your blood sugar level more regularly and talk to your doctor about possible changes in your insulin dose.

How and where to inject the insulin

Insulatard is administered by injection under the skin (subcutaneous administration). It should never be injected directly into a vein (intravenous injection) or muscle (intramuscular injection).

With each injection, change the injection site within the area of skin you use. This can reduce the risk of developing lumps and depressions in the skin, see section 4. The best areas for injection are: the front of the waist (abdomen), the gluteal region, the front of the thigh, or the upper arm. The effect of the insulin will be faster if the injection is made in the waist (abdomen). You should measure your blood sugar level regularly.

How to use Insulatard

Insulatard vials must be used with insulin syringes graduated in the corresponding unit scale.

If you only use one type of insulin

  1. Turn the vial between your hands until the liquid has a uniformly white and cloudy appearance. Resuspension is easier when the insulin has reached room temperature. Draw into the syringe the same amount of air as the dose of insulin you are going to inject. Inject the air into the vial.
  2. Turn the vial and syringe upside down and draw out the correct dose of insulin into the syringe. Remove the needle from the vial. Then, expel the air from the syringe and check that the dose is correct.

If you need to mix two types of insulin

  1. Just before use, turn the Insulatard vial between your hands until the liquid has a uniformly white and cloudy appearance. Resuspension is easier when the insulin has reached room temperature.
  2. Draw into the syringe the same amount of air as the dose of Insulatard. Inject the air into the vial containing Insulatard and remove the needle.
  3. Draw into the syringe the same amount of air as the dose of fast-acting insulin. Inject the air into the vial containing the fast-acting insulin. Then, turn the vial and syringe upside down and draw out the prescribed dose of fast-acting insulin. Expel the air from the syringe and check that the dose is correct.
  4. Insert the needle into the Insulatard vial, turn the vial and syringe upside down, and draw out the prescribed dose. Expel the air from the syringe and check that the dose is correct. Inject the mixture immediately.
  5. Always mix Insulatard and fast-acting insulin in the same order.

How to inject Insulatard

?The insulin should be injected under your skin. Use the injection technique advised by your doctor or nurse.

?Keep the needle under the skin for at least 6 seconds to ensure that all the insulin is injected.

? Discard the needle and syringe after each injection.

If you use more insulin than you should

If you use too much insulin, your blood sugar level will drop too low (hypoglycemia). See Summary of serious and very common side effects in section 4.

If you forget to use the insulin

If you forget to use the insulin, your blood sugar level may rise too high (hyperglycemia). See Effects of diabetes in section 4.

If you stop using the insulin

Do not stop using the insulin without talking to your doctor first, who will explain what you should do. Stopping the insulin may cause a high increase in your blood sugar level (severe hyperglycemia) and ketoacidosis. See Effects of diabetes in section 4.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Summary of Serious and Very Common Adverse Effects

Decrease in Blood Sugar Level (Hypoglycemia)is a very common adverse effect. It can affect more than 1 in 10 people.

Blood sugar levels can drop if:

  • Too much insulin is injected.
  • You eat very little or skip a meal.
  • You do more physical exercise than usual.
  • You drink alcohol, see Use of Insulatard with alcohol in section 2.

Signs of a drop in blood sugar level: cold sweat, cold and pale skin, headache, rapid heartbeat, feeling of discomfort, excessive appetite, temporary visual disturbances, drowsiness, unusual fatigue and weakness, nervousness or tremors, anxiety, confusion, difficulty concentrating.

A severe drop in blood sugar level can lead to loss of consciousness. If left untreated, it can cause brain damage (temporary or permanent) and even death. You can regain consciousness more quickly if someone who knows how to do it administers a glucagon injection to you. If you are given glucagon, you should also take glucose or a sugary product as soon as you regain consciousness. If you do not respond to glucagon treatment, you should go to the hospital immediately.

What to do if you suffer from a drop in blood sugar level:

? If you suffer from a drop in blood sugar level, take glucose tablets or another product with a high sugar content (e.g., candies, cookies, fruit juice). If possible, measure your blood sugar level and rest. Always carry glucose tablets or sugary products with you, just in case.

? When the symptoms of low blood sugar have disappeared or when your blood sugar level has stabilized, continue with your usual insulin treatment.

? If your blood sugar level is so low that you faint, if you have needed a glucagon injection, or if you have had many episodes of low blood sugar, talk to your doctor. You may need to adjust the dose or frequency of insulin administration, your eating habits, or exercise.

Inform relevant people that you have diabetes and what the consequences may be, such as the risk of fainting (loss of consciousness) due to low blood sugar. Let them know that if you faint, they should turn you onto your side and seek medical help immediately. They should not give you food or drinks, as you may choke.

A Severe Allergic Reactionto Insulatard or one of its components (called a systemic allergic reaction) is a very rare but potentially life-threatening adverse effect. It can affect up to 1 in 10,000 people.

Consult your doctor immediately:

  • If allergy symptoms spread to other parts of your body.
  • If you suddenly do not feel well and have sweats, feeling of discomfort (nausea), difficulty breathing, rapid heartbeat, or dizziness.

? If you notice any of these symptoms, seek medical help immediately.

Changes in the Skin at the Injection Site: If you inject insulin in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy) (can affect up to 1 in 100 people). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis; the frequency of this is unknown). Insulin may not work very well if injected into a lumpy, shrunken, or thickened area. Change the injection site to help avoid these skin changes.

List of Other Adverse Effects

Uncommon Adverse Effects

May affect up to 1 in 100 people.

Allergy Symptoms:local allergic reactions (pain, redness, hives, inflammation, bruising, swelling, and itching) can occur at the injection site. They usually disappear a few weeks after starting insulin use. If they do not disappear or spread throughout the body, you should consult your doctor immediately. Also, see the severe allergic reactions mentioned above.

Diabetic Retinopathy(eye disease related to diabetes that can cause vision loss): if you have diabetic retinopathy and your blood sugar level improves very quickly, retinopathy can worsen. In this case, you should consult your doctor.

Joint Inflammation:when starting insulin treatment, fluid accumulation can cause inflammation of the ankles and other joints. This effect usually disappears quickly. If it does not, talk to your doctor.

Very Rare Adverse Effects

May affect up to 1 in 10,000 people.

Vision Problems:when starting insulin treatment, your vision may be affected, but it is usually temporary.

Painful Neuropathy(pain due to nerve damage): if your blood sugar level improves very quickly, you may experience pain related to the nerves. This is known as acute painful neuropathy and is usually transitory.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

Effects Derived from Diabetes

High Blood Sugar Level (Hyperglycemia)

You may experience high blood sugar levels if:

  • Not enough insulin is injected.
  • You forget to inject insulin or stop using it.
  • You repeatedly inject less insulin than you need.
  • You have an infection and/or fever.
  • You eat more than usual.
  • You do less physical exercise than usual.

Warning signs of high blood sugar levels:

The warning signs appear gradually and include frequent urination, thirst, loss of appetite, feeling of discomfort (nausea or vomiting), drowsiness or fatigue, dry and reddened skin, dry mouth, and fruity breath odor (acetone).

What to do in case of high blood sugar levels:

? If you experience any of the above symptoms: check your blood sugar level and the presence of ketones in your urine if possible, and then consult your doctor immediately.

? They can be symptoms of a very serious condition called diabetic ketoacidosis (acid buildup in the blood due to the body breaking down fat instead of sugar). If left untreated, it could lead to a diabetic coma and even death.

5. Storage of Insulatard

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the label and carton after EXP. The expiration date is the last day of the month indicated.

Before Opening:store in a refrigerator (between 2°C and 8°C). Keep away from the cooling element. Do not freeze.

During Use or as a Spare:do not refrigerate or freeze. It can be carried and stored at room temperature (below 25°C) for up to 6 weeks.

Always keep the vial in the outer packaging when not in use to protect it from light.

Discard the needle and syringe after each injection.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Insulatard

  • The active ingredient is human insulin. Insulatard is an isophane human insulin (NPH) suspension. Each ml contains 100 IU of human insulin. Each vial contains 1,000 IU of human insulin in 10 ml of injectable suspension.
  • The other ingredients are zinc chloride, glycerol, metacresol, phenol, disodium phosphate dihydrate, sodium hydroxide, hydrochloric acid, protamine sulfate, and water for injectable preparations.

Appearance of the Product and Package Contents

Insulatard is presented as an injectable suspension. After resuspension, the liquid should have a uniformly white and cloudy appearance.

Package sizes of 1 or 5 vials of 10 ml or a multipack of 5 packs of 1 vial of 10 ml. Not all pack sizes may be marketed.

The suspension is aqueous, white, and cloudy in appearance.

Marketing Authorization Holder

Novo Nordisk A/S,

Novo Allé, DK-2880 Bagsværd, Denmark

Manufacturer

The manufacturer can be identified by the batch number printed on the carton and label:

  • If the second and third characters are S6 or ZF, the manufacturer is Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd, Denmark.
  • If the second and third characters are T6, the manufacturer is Novo Nordisk Production SAS, 45 Avenue d’Orléans, F-28000 Chartres, France.

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicine is available on the European Medicines Agency's website: http://www.ema.europa.eu.

Online doctors for INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL

Discuss questions about INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL?
INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL?
The active ingredient in INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL is insulin (human). This information helps identify medicines with the same composition but different brand names.
Who manufactures INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL?
INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL is manufactured by Novo Nordisk A/S. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to INSULATARD 100 IU/ml INJECTABLE SUSPENSION IN VIAL?
Other medicines with the same active substance (insulin (human)) include HUMULINA NPH 100 IU/ML INJECTABLE SUSPENSION IN VIAL, HUMULINA NPH KWIKPEN 100 IU/ML INJECTABLE SUSPENSION, INSULATARD FLEXPEN 100 IU/ml INJECTABLE SUSPENSION IN PRE-FILLED PEN. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media